Suven Life Sciences LimitedNSE: SUVEN

July 08, 2026BM outcome 08.07.2026

· Issued by Suven Life Sciences Limited

CSD/BM/SE/2026-27

Date: July, 08, 2026 To Department of Corporate Services BSE Limited 25th Floor, P. J. Towers, Dalal Street, Mumbai - 400 001 To Listing Department National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex Bandra (E), Mumbai - 400 051 Scrip Code: 530239 Scrip Symbol: SUVEN

Dear Sir/Madam,

Sub: Outcome of the Meeting of Board of Directors

Pursuant to the provisions of Regulation 30 of the SEBI (LODR) Regulations, 2015, as amended and other applicable provisions of law, this is to inform that the Board of Directors of the Company, at its meeting held today i.e. July 08, 2026, has inter-alia considered and approved the following:

  1. Allotment of 1,85,70,133 Equity Shares of the Company on preferential basis upon conversion 1,85,70,133 fully paid warrants

    The Board of Directors has approved Conversion of 1,85,70,133 fully paid warrants and issued & allotted 1,85,70,133 (One Crore Eighty-Five Lakhs Seventy Thousand One Hundred thirty- three only) Equity Shares of Rs.1/- each to the following Non-Promoter Persons/ Entities at an issue price of Rs. 134/- per share on preferential basis in accordance with SEBI (Issue of Capital and Requirements) Regulations, 2018.

    Sl. No.

    Non-promoter persons/entities

    No. of Equity

    shares allotted

    1.

    TEJAS TRIVEDI

    37,31,343

    2.

    KETAN CHHOTALAL SHETH

    20,00,000

    3.

    ITI HOLDINGS AND INVESTMENT PRIVATE LIMITED

    18,65,670

    4.

    ARUN NAHAR

    15,00,000

    5.

    JAGDISH N MASTER

    15,00,000

    6.

    NILESH KISHORE SHAH

    12,00,000

    7.

    NIMESH ARVIND DOSHI

    11,94,100

    8.

    ORACULAR ADVISORY PRIVATE LIMITED

    11,25,000

    9.

    ATMAN INVESTMENTS PRIVATE LIMITED

    10,00,000

    10.

    ZAPFIN TEKNOLOGIES PRIVATE LIMITED (Formerly,

    Trishakti Power Holdings Private Limited)

    10,00,000

    11.

    TIKRI PARTNERS LLP

    7,46,260

    12.

    CAMPBELL ADVERTISING PRIVATE LIMITED

    4,47,760

    13.

    NIMISH CHANDULAL SHAH

    3,60,000

    14.

    SHARAD NANDLAL SHAH

    3,00,000

    15.

    NEHA IYENGAR

    3,00,000

    16.

    SHANTIKUMAR GIRDHARLAL SHAH

    1,50,000

    17.

    CHARU MAHENDRA PARIKH

    1,50,000

    Total

    1,85,70,133

    Further it is informed that the Company has received from the above said allottees 100% consideration amount aggregating to Rs. 248,83,97,822/- in compliance with SEBI (ICDR) Regulations, 2018.

    Consequently, the paid-up equity share capital of the company stands increased to the following:

    Particulars

    No. of Equity

    Shares

    Amount in INR

    Pre-issue subscribed & paid-up capital

    263992553

    26,39,92,553/-

    Post-issue subscribed & paid-up capital

    282562686

    28,25,62,686/-

    Disclosure required pursuant to Regulation 30 and Schedule III of the SEBI (LODR) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026 is enclosed herewith as Annexure A.

  2. Re-appointment of Independent Director

    Based on the recommendation of the Nomination and Remuneration Committee in its meeting held today i.e. 08th July, 2026, the Board of Directors has approved the re-appointment of Dr. Vajja Sambasiva Rao (DIN: 09233939) as Non-Executive Independent Director of the Company for a second term of Five (5) years w.e.f. 21st January, 2027 to 20th January, 2032, subject to approval of the Members of the Company at the ensuing Annual General meeting.

    Disclosure required pursuant to Regulation 30 and Schedule III of the SEBI (LODR) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026 is enclosed herewith as Annexure B.

  3. Incorporation of Wholly owned Subsidiary (WOS) In Singapore

Disclosure required pursuant to Regulation 30 and Schedule III of the SEBI (LODR) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026 is enclosed herewith as Annexure C

The Board Meeting commenced at 11:50 A.M (IST) and concluded at 12:35 P.M (IST). This is for your information and records.

Thanking you.

Yours faithfully,

For Suven Life Sciences Limited

Kandari Sangeetha Laxmi

Digitally signed by Kandari Sangeetha Laxmi

Date: 2026.07.08

12:45:24 +05'30'

K. Sangeetha Laxmi

Company Secretary and Compliance officer Encl: as above

ANNEXURE A Disclosure of information pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Sl.

no.

Particulars

Details

a)

Type of securities proposed to be issued (viz. equity shares,

convertibles etc.);

Fully paid-up equity shares upon conversion of warrants

b)

Type of issuance (further public offering, rights issue, depository receipts (ADR/ GDR), qualified

institutions placement, preferential allotment etc.);

Preferential Allotment in accordance with Chapter V of the SEBI (ICDR) Regulations, 2018 and other applicable law.

c)

Total number of securities proposed to be issued or the total amount for which the securities will be issued

(approximately);

1,85,70,133 Equity Shares of face value of Rs. 1/- each pursuant to conversion of 1,85,70,133 warrants at an issue price of ₹ 134/- per warrant, for an aggregate consideration of Rs. 248,83,97,822/- to below allottee.

d)

In case of preferential issue, the listed entity shall disclose the following additional details to

the stock exchange(s):

i. number of investors;

17

ii. names of the investors;

Sl.

No

Non-Promoter entities/

Persons

No. of Equity

Shares allotted

1

TEJAS TRIVEDI

37,31,343

2

KETAN CHHOTALAL SHETH

20,00,000

3

ITI HOLDINGS AND

INVESTMENT PRIVATE LIMITED

18,65,670

4

ARUN NAHAR

15,00,000

5

JAGDISH N MASTER

15,00,000

6

NILESH KISHORE SHAH

12,00,000

7

NIMESH ARVIND DOSHI

11,94,100

8

ORACULAR ADVISORY PRIVATE

LIMITED

11,25,000

9

ATMAN INVESTMENTS PRIVATE

LIMITED

10,00,000

10

ZAPFIN TEKNOLOGIES PRIVATE

LIMITED (Formerly, Trishakti Power Holdings Private Limited)

10,00,000

11

TIKRI PARTNERS LLP

7,46,260

12

CAMPBELL ADVERTISING

PRIVATE LIMITED

4,47,760

13

NIMISH CHANDULAL SHAH

3,60,000

14

SHARAD NANDLAL SHAH

3,00,000

15

NEHA IYENGAR

3,00,000

16

SHANTIKUMAR GIRDHARLAL

SHAH

1,50,000

17

CHARU MAHENDRA PARIKH

1,50,000

iii. post allotment of securities -outcome of the subscription

Pursuant to conversion, the issued, subscribed and paid-up equity share capital of the Company stands increased to Rs. 282562686/- consisting of 282562686 fully paid-up equity shares of Rs. 1/- each.

iv. issue price/ allotted price

(in case of convertibles)

Rs. 134/- per share

v. in case of convertibles -intimation on conversion of securities or on lapse of the tenure of the instrument;

Allotment of 18570133 equity shares pursuant to the conversion of warrants at an issue price of Rs. 134/- each (face value of Rs. 1/- each and premium of Rs. 133/- each) upon receipt of 100% consideration amount from above mentioned allottee amounting to Rs. 248,83,97,822/-

e)

any cancellation or termination of proposal for issuance of securities including reasons

thereof.

Not applicable

Banjara Hills I Hyderabad - 500 034 I Telangana I India I CIN: L24110TG1989PLC009713 Tel: 91 40 2354 1142/ 1152 Email: info@suven.com website: www.suven.com

Earlier from Suven Life Sciences

All Suven Life Sciences news releases